drugset / Trial / NCT00970775
AZD2423 Single Ascending Dose Study in Healthy Japanese Subjects
RandomizedParallel-groupQuadruple-blindBasic science
Summary
This is a Phase I, single centre, randomised, double-blind, placebo-controlled, parallel group study to assess the safety, tolerability and pharmacokinetics of AZD2423 following single ascending dose administration to healthy Japanese subjects.
Timeline
- Start
- 2009-08
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD2423 | Unknown | — | Oral |
Indications
No indication recorded.